Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds

February 22, 2024

FORT LAUDERDALE, Fla., Feb. 22, 2024 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc. (Nasdaq:MOTS, or “Motus” or “the Company”), a medical technology company focused on improving endoscopic outcomes and experiences, today announced that it has entered into a definitive agreement for the immediate exercise of an outstanding Series B common stock purchase warrant held by an institutional investor to purchase an aggregate of 2,933,334 shares of the Company’s common stock for gross proceeds to the Company of approximately $2.7 million.

Read more at globenewswire.com

Related news for (MOTS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.